No abstract available
Publication types
-
Clinical Trial, Phase II
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents / therapeutic use*
-
Drug Resistance, Neoplasm*
-
Follow-Up Studies
-
Humans
-
Imidazoles / therapeutic use*
-
Leukemia, Hairy Cell / drug therapy*
-
Leukemia, Hairy Cell / pathology
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / pathology
-
Oximes / therapeutic use*
-
Pilot Projects
-
Prognosis
-
Prospective Studies
-
Salvage Therapy*
-
Survival Rate
Substances
-
Antineoplastic Agents
-
Imidazoles
-
Oximes
-
dabrafenib